It is commonly known that the majority of endometrial cancers show estrogen-dependent proliferation, but the carcinogenic mechanisms are not completely explained except for some specific single oncogenes and tumor suppressor genes (e.g., p53) mutations. This evidence concerns the gene TP53 and endometrial cancer.